Scleral changes induced by atropine in chicks as an experimental model of myopia

Patricia Gallego1, Carmen Martínez-García, Pablo Pérez-Merino

  • 1Department of Cell Biology, Histology and Pharmacology, School of Medicine, University of Valladolid, Valladolid, Spain. patricia.gallego.munoz@uva.es

Insights

Intravitreal atropine treatment in chicks with induced myopia led to significant refractive error recovery. Atropine altered scleral growth, thickening the fibrous layer and thinning the cartilaginous layer, halting ocular growth.

Area of Science:

  • Ophthalmology
  • Developmental Biology
  • Animal Models

Background:

  • Myopia, a common vision disorder, is characterized by excessive eye elongation.
  • Understanding the mechanisms of scleral growth is crucial for developing myopia control strategies.
  • The form-deprived chick model provides a valuable platform for studying myopia development and potential interventions.

Purpose of the Study:

  • To investigate the impact of intravitreal atropine on scleral growth and refractive error in a chick model of myopia.
  • To determine if atropine can modulate the structural changes in the sclera associated with myopia progression.

Main Methods:

  • Chicks were subjected to monocular form deprivation to induce myopia.
  • Groups received intravitreal injections of atropine or a control vehicle.
  • Refractive error, axial length, and scleral histology (fibrous and cartilaginous layers) were assessed.

Main Results:

  • Form-deprived eyes exhibited myopic refractive errors.
  • Atropine treatment resulted in hyperopic shifts and statistically significant changes in refractive error.
  • Scleral analysis revealed a thickened fibrous layer and thinned cartilaginous layer in atropine-treated eyes compared to controls.
  • Axial length changes correlated with refractive error modifications.

Conclusions:

  • Intravitreal atropine can reverse myopia and halt ocular growth in this experimental model.
  • Atropine induces specific morphological changes in the sclera, including fibrous layer thickening and cartilaginous layer thinning.
  • These scleral alterations suggest atropine's mechanism of action involves direct effects on scleral tissue, influencing ocular growth regulation.
Abstract

Related Concept Videos